Sirolimus for Kaposi's sarcoma in renal-transplant recipients. - Wikidata - awgldk - TriplyDB

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

http://www.wikidata.org/entity/Q34556363

about

Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China Posttransplantation malignancy in a patient presenting with weight loss and changed bowel habits: a case report Therapy Insight: AIDS-related malignancies—the influence of antiviral therapy on pathogenesis and management Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas Targeting the mTOR signaling network for cancer therapy Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway Update on kidney transplantation in human immunodeficiency virus infected recipients Neoplastic disease after liver transplantation: Focus on de novo neoplasms Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?Rapalogs in cancer prevention: anti-aging or anticancer?Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug.Targeting the phosphoinositide 3-kinase pathway in cancer Tuberous Sclerosis Complex Associated with Vascular Anomalies or Overgrowth.Outcomes of kidney transplantation in HIV-infected recipients Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study.Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model.Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects.The pros and the cons of mTOR inhibitors in kidney transplantation.Validation of anti-aging drugs by treating age-related diseases.Growth and aging: a common molecular mechanism.The PIK3CA gene as a mutated target for cancer therapy.mTORC1 activation in childhood ependymoma and response to sirolimus.KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.Update on HHV-8-Associated Malignancies Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.From rapalogs to anti-aging formula.Hormesis and Defense of Infectious Disease.Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency.

P2860

Q21245098-46FEDA93-642B-41A9-A89E-C5BE05F4F6FF Q21261410-F9346AD7-FC95-4066-8281-B7A8A0D6E0CD Q22251070-FF06C807-F96E-4AFC-968C-45A4B5A428FB Q24246340-24A754CC-1A85-427F-9916-EEBB156CA8CE Q24609227-AE71F8DA-CA10-4144-B715-BD2620BE32B4 Q24623371-4328A645-84EA-4E06-99D5-E9FD6E655BA5 Q24658269-2F68E90C-7AD8-4375-8C37-03B957411613 Q24658334-95D4F7C9-D2FC-4848-8988-85A743767214 Q24673299-126138A8-F26C-4DCE-B3BC-B75CE5D3DF93 Q26700049-22AD3DB3-6E59-4227-995A-412FABB0D7C3 Q26741544-9F6F8D49-FEF1-40E1-B0EB-AD248B40A6B9 Q26798306-390CB5E6-D9B4-4AC7-8047-19EE56E90569 Q26823023-A3A72B34-6386-4AAD-8C49-E735735BC738 Q26851436-27B0C080-B453-42E2-8245-0A74641F63C0 Q26866151-FEDA0BF9-211A-4FA1-937F-7D9C24CBC878 Q27020978-DA376F8B-9213-4D13-A749-E703CA56F68D Q28067598-EF82B6D6-575A-4C1F-9A98-266B0348450E Q28307873-4DDE27F2-9647-4C22-99B1-80A123356C66 Q28476740-17A20387-6E19-45BD-A2BC-0D2E2CDAFBF5 Q29615809-CC6F99F4-470A-4DAF-9F0E-3C0C40FE9C8E Q30248734-E66E1E2E-EB44-4CB3-98DC-CBDFD4A65EFB Q30432292-614FBB3E-C0A3-4AB4-A7FF-49E6A130B407 Q33280039-710D747B-8113-424B-9687-3BD0111DB357 Q33299027-FE5D9CBB-45FE-4308-96CF-09AFDE6F6A70 Q33316872-A61A9E71-59F8-456D-87B6-26967F72F332 Q33393707-2D0F5C89-A8C9-4B39-8229-F200E4F0403D Q33412367-120C40F6-7BBA-440A-930A-F30AAB5D8FF4 Q33588700-7A06A497-B994-4F4E-9A1D-89476282281A Q33588716-287FE0AF-50ED-4D98-9A83-E47C6813510E Q33699378-C9897C43-BA5E-4BD3-976E-07804816BF17 Q33746501-CAC8180F-2011-4919-BD08-5C982681760B Q33761091-42D8F6A5-BB53-4F61-A70B-9BFF16402B9D Q33793543-9496056E-C8C6-4D4F-A36F-FABF824A6640 Q33814153-3C763FFF-3BFA-4148-AF9D-3231DCE55467 Q33819076-525666A8-73AC-4EC0-A56F-4E8F6509C754 Q33829205-8F3BBBE5-372E-45EB-AAA6-097E474A1183 Q33838971-04B1FE42-09C4-4F8A-AE28-D1371E48F0AD Q33886847-53EA000B-6400-430D-85CD-3C60C0DA1DC7 Q33895137-AB620FBD-D40F-442E-8BA7-F72E1C2E3CD7 Q33923893-EC558841-3028-423E-A1ED-9EC0BAFFA9B7

P2860

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

http://www.wikidata.org/entity/Q34556363

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@ast

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@en

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@nl

type

label

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@ast

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@en

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@nl

prefLabel

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@ast

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@en

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@nl

P1433

Q34556363-CCF6B799-3D06-4671-956F-EE9214CE9030

P1476

Q34556363-2AEAD6D5-3DC5-431D-AF13-D8F2FF22B694

P2093

Q34556363-2B8C0CE6-911C-4751-AAA8-372693B8A67C

Q34556363-2ED0B812-1199-44A5-A9E9-100C4B629427

Q34556363-3F805E5D-0265-495E-8A5F-7ADFA0918916

Q34556363-4EF2AE48-D4BF-4696-BA70-3DF6E60427A2

Q34556363-5B79625E-4FA9-440C-BAAD-948AF7592EF4

Q34556363-7A6EC567-A698-4A8A-9BAB-484C56980640

Q34556363-933EED9C-7341-4A6B-8233-6553B93B01EA

Q34556363-C6FBFD8F-2BD0-4AEF-ABAC-80542F1E830E

Q34556363-D0E98567-EAE2-48C3-8A48-42B734BE0313

Q34556363-EB52C16A-9C18-459F-9355-07E7F849FAAC

P304

Q34556363-49350B8D-6D2C-45BA-AEEF-66845F2FFA2A

P31

Q34556363-44C95D87-36E9-4A75-BFD2-32EF6AEE6232

P356

Q34556363-EB7ED539-27BC-488A-9831-BFD86BB9D1F5

P407

Q34556363-C9E58976-92CA-4C94-B892-BCAE60B8DBE4

P433

Q34556363-13F4B23D-8B6A-4978-A5F7-AAD10788BB66

P478

Q34556363-151FBB89-5972-4582-BB9E-79E8FC8938B5

P577

Q34556363-DA23D9F8-D652-4FE1-B310-DDF8E5F92D70

P698

Q34556363-D62FBEE8-6250-4A4D-8E95-7562EC45C34C

P356

P1433

The New England Journal of Medicine

P1476

Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

@en

P2093

Antonella Loverre

http://www.w3.org/2001/XMLSchema#string

Antonio Schena

http://www.w3.org/2001/XMLSchema#string

Barbara Infante

http://www.w3.org/2001/XMLSchema#string

Elena Ranieri

http://www.w3.org/2001/XMLSchema#string

Francesco Paolo Schena

http://www.w3.org/2001/XMLSchema#string

Giovanni Stallone

http://www.w3.org/2001/XMLSchema#string

Giulio Maggio

http://www.w3.org/2001/XMLSchema#string

Giuseppe Grandaliano

http://www.w3.org/2001/XMLSchema#string

Loreto Gesualdo

http://www.w3.org/2001/XMLSchema#string

Salvatore Di Paolo

http://www.w3.org/2001/XMLSchema#string

P304

1317-1323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA042831

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

352

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15800227

http://www.w3.org/2001/XMLSchema#string